ePatient / Health 2.0 - A Key Factor for New and Innovative Business Models for the Life Sciences Industry

17 November 2011, Düsseldorf, Germany.
InterComponentWare AG (ICW), an internationally focused company specializing in technology solutions for the healthcare market, invites to a podium discussion during the Medica Media Forums. Follow the newest discussions at Medica 2011 in Düsseldorf and take advantage of the opportunity to discuss with subject matter experts. ICW representatives are looking forward to meeting you at 3:00 pm on Thursday, 17th November 2011 at the MEDICA Media Forum in Hall 15 (Stand A11).

Today's patients are well informed and capable of making their own decisions when it comes to healthcare. When making their decisions about health products and services they utilize both real-world channels and electronic channels of the internet. Increasingly, the "ePatient" is becoming a factor in the "Health 2.0 ecosystem".

ICW develops innovative solutions for the healthcare system under the slogan "connect. manage. personalize." Get a new perspective and discover how solutions from ICW can help you to network disparate actors, support care-critical processes, and create options for modern interaction to engage the patient in the treatment process.

Take time to visit ICW at MEDICA in Hall 15, Stand F35 to get an interesting look at modern eHealth solutions.

Arrange a personal appointment here: http://www.icw-global.com/en/press-events/medica-appointment.html, or send an email to Mr. Silvio Frey This email address is being protected from spambots. You need JavaScript enabled to view it.
Upon request ICW representatives will also gladly send complementary admission tickets or informational material.

About ICW
ICW is an international healthcare technology provider. Our robust software and techniologies help to network the various actors, optimize care and engage patients in the treatment process. Our products are based on the ICW eHealth Platform, a suite of powerful technology components that support the quick assembly of eHealth solutions and the flexible implementation of integration scenarios. Together with our partners, our goal is to enable interoperability among healthcare stakeholders to harvest potentials and realize innovative forms of cooperation and collaboration. For more information go to www.icw-global.com.

Most Popular Now

Novo Nordisk announces plans to transform its appr…

Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious c...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Sat...

World's largest Alzheimer's survey reveals most ad…

Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest glob...

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Pre-clinical success for a universal flu vaccine o…

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Co...

Discovery could explain failed clinical trials for…

Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trial...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

Aspirin found not to prolong healthy aging

Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial p...

The Lancet Respiratory Medicine publishes first Ph…

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

Clinical gene discovery program solves 30 medical …

A table in a recently published paper tells the story of 30 families who have, sometimes after years of searching, finally received an answer about the condition that has...